Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study.
Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study.
复制标题
DOI:
10.1007/s11892-013-0381-0
复制
发表时间:
2013-08
影响因子:
4.2
通讯作者:
Doria, Alessandro
中科院分区:
文献类型:
--
作者:
Maahs, David M.;Caramori, Luiza;Cherney, David Z. I.;Galecki, Andrzej T.;Gao, Chuanyun;Jalal, Diana;Perkins, Bruce A.;Pop-Busui, Rodica;Rossing, Peter;Mauer, Michael;Doria, Alessandro
关键词:
Diabetic kidney disease causes significant morbidity and mortality among people with type 1 diabetes (T1D). Intensive glucose and blood pressure control have thus far failed to adequately curb this problem and therefore a major need for novel treatment approaches exists. Multiple observations link serum uric acid levels to kidney disease development and progression in diabetes and strongly argue that uric acid lowering should be tested as one such novel intervention. A pilot of such a trial, using allopurinol, is currently being conducted by the Preventing Early Renal Function Loss (PERL) Consortium. Although the PERL trial targets T1D individuals at highest risk of kidney function decline, the use of allopurinol as a renoprotective agent may also be relevant to a larger segment of the population with diabetes. As allopurinol is inexpensive and safe, it could be cost-effective even for relatively low-risk patients, pending the completion of appropriate trials at earlier stages.
登录
查看更多内容
影响因子:
120.7
作者:
de Boer, Ian H.;Rue, Tessa C.;Hall, Yoshio N.;Heagerty, Patrick J.;Weiss, Noel S.;Himmelfarb, Jonathan
通讯作者:
Himmelfarb, Jonathan
影响因子:
7.7
作者:
Hovind P;Rossing P;Tarnow L;Johnson RJ;Parving HH
通讯作者:
Parving HH
影响因子:
16.2
作者:
Hoerger, Thomas J.;Gregg, Edward W.;Saaddine, Jinan B.
通讯作者:
Saaddine, Jinan B.
影响因子:
4.7
作者:
Chohan, Saima;Becker, Michael A.;Jackson, Robert L.
通讯作者:
Jackson, Robert L.
影响因子:
13.2
作者:
Iseki, K;Ikemiya, Y;Takishita, S
通讯作者:
Takishita, S